American Senator says that diabetes and weight loss drugs changed his life, which is the reason for this

An American Senator said that GLP-1 is not his life-and now it calls for widespread access to anti-metaphysical drugs.

At an introduction to the New York Times on April 8, Senator John Vitirman, De Pa, wrote about his experience with Monjaro (Terzopatide).

A medical prescription is used primarily to treat type 2 diabetes.

OzemPIC’s health benefits continue to grow, but do you deserve risks?

Fetterman was prescribed in July 2025.

“your Survivors of stroke“I was interested in studies that appear (mounjaro) can significantly reduce the risk of major heart events,” Senator wrote.

“Although I started taking it for Heart healthI am surprised by how best I made me feel in all fields. He had a great impact on my public health. ”

“Pain, pain and hardness have disappeared.

The study discovers that genetic cholesterol has been eliminated by a new drug, which reduces

Besides reducing blood sugar, GLP-1 medications have also been linked to a range of other benefits, including improving heart health, nervous function and metabolic health, Fox News Digital said.

ELI Lilly, Mountjaro Maker, offers another version of the drug called Zepbound, which is the same drug for weight loss and chronic weight management and Sleeping breathing.

Other GLP-1 drugs include OzPic, Wegovy, Victoza and Saxenda, all of which were made by New Nordisk.

Fetterman indicated that GLP-1 drugs have beneficial effects on cholesterol, heart rate and heart inflammation.

“Some recent studies indicate that they may even help in a limit alcoholism Supporting the cognitive function, and perhaps slowing or preventing circumstances such as Parkinson’s and Marzheimer’s “, written in the Times OP-ED.

“Physically, I feel a decade younger than time, as well as more clear and more optimistic than I have been years ago.”

At the forefront, Fetterman called for an expanded access to These medicationsWhich can cost up to $ 1,000 of the pocket if it is not covered with insurance.

“At the present time, Medicare only covers these drugs under specific conditions, such as diabetes or increased heart risk,” wrote. “Medicaid coverage is more limited.”

Fetterman added that he was not compensated for sharing his experience.

OzemPIC “Microdoss” is the direction of new weight loss

“I am just a man who benefited from these medications and wants to make sure that anyone else can benefit from it can get them as well,” he wrote.

While Fetterman participates HHS SEC. Robert F. Kennedy He said he believed that the views of the son on giving priority to nutrition and a healthy life, believed that medications are necessary for some.

I fully agree that the diet Lifestyle of the issue – a lot. But the diet alone is not enough. ”

“For millions of Americans with serious health issues, the drug can be a decisive first step to restore enough control of their health to start making a meaningful lifestyle.”

Doctors discuss the benefits and access

Dr. Mark Segel, professor of clinical medicine at New York University, Langon Health and Fox News, noted that the medical indications, including Ozzic and Wugovi, are “very important drugs” Type 2 diabetesWith increased use of obesity.

“Although these drugs have useful uses of the appearance of the heart and fat – as well as the brain and reduce dementia – studies are continuing and more data is still needed,” he told Fox News Digital.

the first Obesity Siegel said that lifestyle changes, including exercise, improve diet and optimal sleep.

“After saying this, these drugs that lose weight (including Zepbound) are also good tools when lifestyle is not enough,” he pointed out.

“It helps to prevent diseases that go down, such as heart disease, stroke, high blood pressure and sleep breathing, which tend to come from obesity.”

He added: “In general, we provide the funds of the health care system, so I would like to see medical care and the doctor approved for diabetes Weight loss“

Click here to register in our health newsletter

Dr. Brett Osborne, a neurologist at Florida and an expert on life, said he describes the GLP-1 of his patients since 2019.

“Mounjaro and his cousins ​​are not just weight loss tools-they are buttons reset metabolism,” he told Fox News Digital.

“People with metabolic syndrome do not need lectures on turnip and the importance of exercise. They need help.”

Osborne agreed that the lifestyle is necessary, but it is “rarely enough.”

“GLP-1S gives patients momentum by getting a rolling ball,” he said. “And when this happens, healthy habits are formed. The diet improves. Movement improves. People begin to feel the benefits of healthy life.”

For more health articles, visit www.foxnews.com/health

Osborne noted that these drugs are not cosmetics, but they are therapeutic.

“I have seen what they can do directly: cuts in body fat, inflammation, glucose, triglycerides and insulin resistance – and with those, significant discounts in stroke and heart attack.”

“I think this is a sign that directly aims to Big Pharma.”

The administration of President Donald Trump recently announced that Medicare and Medicaid will not cover medicines, as said Medicare and Medicaid Service Centers late on Friday.

Osborne said the step to prevent coverage is not likely to be effective.

“Trump knows that these medications are working,” said Usborne. “I think this is a sign that directly aims to Big Pharma:” Reducing the price, or Medicare, the largest of the block, “”

Click here to get the Fox News app

“This is not a chapter – it’s influence,” Osborne said.

“President Trump is likely to negotiate even” the price is correct, “which leads to the lack of allocating major medications while improving the health of Americans in conjunction.”